CsA
|
Lower rate of new-onset diabetes after transplant (NODAT)[9]
May have lower neurotoxicity[10]
Reduced the risks after liver transplantation of death, graft loss,
acute rejection and steroid-resistant rejection[9,
11]
|
The serum concentration of TAC is low and unable to reach the target
serum concentration after increasing the dose of TAC.
Severe complications developed such as posterior reversible
encephalopathy syndrome (PRES), seizures and some other CNS
symptoms.[12, 13]
|